Multiple Sclerosis Drugs Market is projected to surge ahead at a CAGR of 4.8% from 2024 to 2032 The Global Multiple Sclerosis Drugs Market size is expected to grow from USD 28.83 billion in 2022 to USD 41.95 billion by 2030, at a CAGR of 4.8% during the forecast period (2023-2030).
Multiple sclerosis (MS) is a chronic neurological condition caused by an unknown inflammatory process in the central nervous system (CNS). It leads to multifocal demyelination and axonal damage, primarily...
0 Shares
425 Views
0 Reviews